Stock RHY RHYTHM BIOSCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Rhythm Biosciences Limited

Equities

RHY

AU000000RHY2

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
 02:10:46 2024-04-19 am EDT 		5-day change 1st Jan Change
0.093 AUD 0.00% Intraday chart for Rhythm Biosciences Limited +2.20% -31.11%
Mar. 21 Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3% MT
Mar. 18 Rhythm Biosciences Limited(ASX:RHY) dropped from S&P/ASX All Ordinaries Index CI

Business Summary

Rhythm Biosciences Limited is an Australia-based medical diagnostics company. The Company is engaged in the development and commercialization of Australian medical diagnostics technology for sale in domestic and international markets. The Company's ColoSTAT a blood-base cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or unwilling to use available screening modalities. ColoSTAT is indicated to screen adults, aged 40 to 85, at average risk for developing Colorectal Cancer (CRC). The test-kit measures five specific biomarkers in the blood that either increase or decrease in quantity when CRC tumors are present.

Managers

Managers TitleAgeSince
Darren Moulton COO
 Chief Operating Officer - -
Trevor Lockett BRD
 Director/Board Member - 17-05-31
Guy Carisbrooke AUD
 Comptroller/Controller/Auditor - 23-09-20
Elena Deak PRN
 Corporate Officer/Principal - 22-10-26
James Barrie SEC
 Corporate Secretary - Dec. 31
Andrea Steele LAW
 General Counsel - 22-02-24

Members of the board

Members of the board TitleAgeSince
Otto Buttula CHM
 Chairman - 19-10-27
Louis Panaccio BRD
 Director/Board Member 67 17-07-31
Susan MacLeman BRD
 Director/Board Member - 23-01-30
Trevor Lockett BRD
 Director/Board Member - 17-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 287,485,366 171,768,452 ( 59.75 %) 0 59.75 %

Shareholders

NameEquities%Valuation
Otto Buttula
14.21 %
34,961,396 14.21 % 2 M $
Loumea Investments Pty Ltd.
3.344 %
8,225,077 3.344 % 509 790 $
Rojo Nero Capital Pty Ltd.
1.795 %
4,416,405 1.795 % 273 729 $
Giokir Pty Ltd.
1.520 %
3,739,932 1.520 % 231 801 $
Eduardo Vom
1.517 %
3,732,285 1.517 % 231 327 $
Hsien Michael Soo
1.373 %
3,376,234 1.373 % 209 259 $
Government of Australia
1.038 %
2,553,573 1.038 % 158 270 $
Natalie Louise Patterson
1.029 %
2,530,164 1.029 % 156 820 $
Daniel Eddington
0.8818 %
2,169,037 0.8818 % 134 437 $
Mark Anthony Rogers
0.8305 %
2,042,858 0.8305 % 126 616 $

Company contact information

Rhythm Biosciences Ltd.

Bio21 Institute 30 Flemington Road

3010, Parkville

+61 3 8256 2880

http://www.rhythmbio.com
address Rhythm Biosciences Limited(RHY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
RHYTHM BIOSCIENCES LIMITED Stock Rhythm Biosciences Limited
-31.11% 14.73M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-14.19% 11.52B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+44.16% 3.27B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-19.90% 2.02B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-38.37% 2.03B
VERACYTE, INC. Stock Veracyte, Inc.
-30.21% 1.44B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+16.18% 1.01B
SEEGENE, INC. Stock Seegene, Inc.
-6.11% 719M
CAREDX, INC Stock CareDx, Inc
-32.75% 418M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-52.35% 339M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. RHY Stock
  4. Company Rhythm Biosciences Limited